These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 5345719)
61. Activity of phosphonomycin in nasal carriers of coagulase-positive staphylococci. Smith JW; Sanford JP Antimicrob Agents Chemother (Bethesda); 1969; 9():346-8. PubMed ID: 5396512 [No Abstract] [Full Text] [Related]
62. Orbital cellulitis in a burned child. Ahmad A; Hayek B; Poulakidas S; Gamelli R Burns; 2005 Aug; 31(5):650-2. PubMed ID: 15993311 [No Abstract] [Full Text] [Related]
63. [The treatment of cutaneous staphylococcal infections]. Colomb D; David D J Med Lyon; 1970 May; 51(187):1199+. PubMed ID: 5479120 [No Abstract] [Full Text] [Related]
64. [Pristinamycine in dermatology]. Christeler A Praxis; 1966 Dec; 55(52):1529-33. PubMed ID: 6013609 [No Abstract] [Full Text] [Related]
65. [Antimicrobic properties and chemico-therapeutic effect of preparation Sh-24]. Groian GA; Sidorchuk II Mikrobiol Zh; 1969; 31(1):73-8. PubMed ID: 5345719 [No Abstract] [Full Text] [Related]
66. Bacterial skin diseases: current thoughts on pathogenesis and management. May ER Vet Clin North Am Small Anim Pract; 2006 Jan; 36(1):185-202, viii. PubMed ID: 16364784 [No Abstract] [Full Text] [Related]
67. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci]. Bouza E; Rodríguez-Créixems M; Muñoz P Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324 [No Abstract] [Full Text] [Related]
68. [Theoretical substantiation of methods for limiting the circulation of drug-resistant staphylococci]. Zueva VS Antibiotiki; 1984 Apr; 29(4):299-311. PubMed ID: 6378082 [No Abstract] [Full Text] [Related]
69. Glycopeptides in the treatment of staphylococcal infections. Daschner FD; Kropec A Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466 [TBL] [Abstract][Full Text] [Related]